Study on Indomethacin-responsive Headaches

Overview

Description of modalities concerning the patient care of headaches sensible to indometacine.

Full Title of Study: “Non Interventional Study on Indomethacin-responsive Headaches”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 1, 2020

Detailed Description

Description of clinical profile, treatment of crisis and background treatment

Interventions

  • Drug: Indometacin
    • patient who are taken indomatacin for headaches and migraine

Clinical Trial Outcome Measures

Primary Measures

  • Description of headaches sensible to indometacine
    • Time Frame: 24 monthes
    • Description of the clinical cases with headaches sensible to indometacine according to the type of headaches.

Participating in This Clinical Trial

Inclusion Criteria

  • patient with a diagnosis of migraine with or without aura, or trigemino-autosomic headaches or other primary headaches – patient who are taking indometacine – patient with written consent form Exclusion Criteria:

  • patient under 18 years – pregnant woman or breastfeeding patient – patient who refuses to participate

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Anne Ducros
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Anne Ducros, Pr – French Society for the Study of Migraine Headache
  • Overall Contact(s)
    • Anne DONNET, 0491384340, Anne.DONNET@ap-hm.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.